News
Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability
Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability
Breakout Antimicrobial Biotechnology Quietly Building Success
The Watchlist: Biosenta Inc. announces licensing agreement
Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions
Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Fillerâ„¢ Particle Encapsulation Technology
Biosenta Announces Engagement of Oak Hill Financial Inc.
Biosenta closes private placement financing
Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Fillerâ„¢
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢
Biosenta Inc. announces further advances in research and development of Tri-Fillerâ„¢
Biosenta announces further advances in research and development of Tri-Fillerâ„¢
Summit-bound CEO sees promising future for Edmonton region
Biosenta Inc. enters into an MOU with Voran Group Ventures Ltd.
University of Calgary researchers encouraged by early findings in the fight against germs
University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry
Biosenta Announces Stock Option Grant
01/28/2021 - Biosenta Announces Note Financing
01/26/2021 - Biosenta Announces Record Revenues